Psilocybin - onset.to

March 10, 2026

Promising Developments in Psychedelics: Insights from Hans Eriksson, MD, PhD

psychiatrictimes.com · Mar 10, 2026 · Hans Eriksson, MD, PhD

Psilocybin Ketamine Article Clinical +2

March 8, 2026

A new “magic mushroom” drug could treat depression without psychedelic hallucinations

sciencedaily.com · Mar 8, 2026

Psilocybin Article Clinical Research Safety

A new “magic mushroom” drug could treat depression without psychedelic hallucinations

sciencedaily.com · Mar 8, 2026 · American Chemical Society

Psilocybin Article Clinical Research Therapy

March 6, 2026

AtaiBeckley’s MDMA EMP-01 targets social anxiety; psychedelics policy updates include Compass trigger bills and Georgia HB 717

themicrodose.substack.com · Mar 6, 2026 · jane c. hu

Psilocybin Ibogaine Article Clinical +4

March 3, 2026

J&J’s blockbuster Spravato is setting the stage for managing psychedelics’ risks

pharmavoice.com · Mar 3, 2026 · Michael Gibney

Psilocybin 5-MeO-DMT Article Clinical +3

February 26, 2026

Psilocybin produces different behavioral and brain-altering effects depending on the dose

psypost.org · Feb 26, 2026 · Eric W. Dolan

Psilocybin Article Clinical Research Safety

February 25, 2026

Collins Cites Surgeon General Nominee's Book To Ask About Her Using Illicit Psychedelic Mushrooms

youtu.be · Feb 25, 2026 · Forbes Breaking News

Psilocybin Video Clinical Policy Research

February 23, 2026

Psilocybin and the Next Phase of Mental Health Innovation | Florian Brand and Lars Wilde (Part 2)

youtu.be · Feb 23, 2026 · Psychedelic Vantage

LSD Psilocybin Video Clinical +5

February 22, 2026

COMP360 Safety Data in Phase 3 TRD Trials, With Steve Levine, MD

hcplive.com · Feb 22, 2026 · Steve Levine, MD

Psilocybin Clinical Research Safety

February 18, 2026

Compass Pathways Announces Pricing of $150 Million Public Offering

businesswire.com · Feb 18, 2026

Psilocybin Article Business Clinical Industry

February 17, 2026

Compass Pathways shares webcast updates on Phase 3 trial MADRS curves for psilocybin therapy

psychedelicalpha.com · Feb 17, 2026

Psilocybin Clinical Industry Research

BREAKING: Second positive Phase 3 for Compass psilocybin with modest magnitude raises questions about dosing benefit

psychedelicalpha.com · Feb 17, 2026

Psilocybin Article Clinical Industry Research

Compass’ Psychedelic Shows Durability In Spades as Path to FDA Clears

biospace.com · Feb 17, 2026 · Heather McKenzie

Psilocybin Business Clinical Policy

February 16, 2026

Single dose of potent psychedelic drug could help treat depression, trial shows

theguardian.com · Feb 16, 2026 · Ian Sample

Psilocybin DMT Article Clinical +2

February 12, 2026

OHSU-led research initiative examines supervised psilocybin in Oregon community settings with a 5-year NIDA award to study safety and effectiveness

news.ohsu.edu · Feb 12, 2026 · Erik Robinson

Psilocybin Article Clinical Policy Research

February 11, 2026

Psychedelic drugs could help terminal cancer patients with existential pain, mental health, and end-of-life dread

nationalgeographic.com · Feb 11, 2026 · Meryl Davids Landau

Psilocybin Article Clinical Policy Therapy

January 31, 2026

Long-term antidepressant effects of psilocybin linked to functional brain changes

psypost.org · Jan 31, 2026 · Karina Petrova

Psilocybin Article Clinical Research Therapy

January 28, 2026

Northwell opens Center for Psychedelics Research and Treatment at Zucker Hillside Hospital with planned trials on psilocybin, MDMA, ketamine and cannabis

libn.com · Jan 28, 2026 · Adina Genn

Psilocybin MDMA Article Clinical +4

January 26, 2026

Effects of psilocybin on personality, psychiatric symptoms, and values: Exploring mediating effects of the acute psychedelic experience

journals.sagepub.com · Jan 26, 2026 · Jess Kerr-Gaffney; Samuel Myrtle; Famia Askari; Catherine Bird; Nadav Liam Modlin; Allan H. Young; James Rucker

Psilocybin Article Clinical Research Therapy

January 20, 2026

Psychedelics of Mice, Men, and Bulldozers | Paul Hutson | TEDxLake Geneva

youtube.com · Jan 20, 2026 · Paul Hutson

LSD Psilocybin Talk Clinical +6

January 8, 2026

Pα+ Psychedelic Bulletin #217: Gilgamesh GM-1020 positive topline, FDA lifts 5-MeO-DMT hold, Compass PTSD design, Cybin becomes Helus

psychedelicalpha.com · Jan 8, 2026

Psilocybin DMT Article Business +3

January 1, 2026

The power of acceptance: acceptance helps prevent psychological torment after a low psilocybin dose, with a real case example

ecstaticintegration.org · Jan 1, 2026 · Jules Evans

Psilocybin Article Clinical Safety Therapy

December 15, 2025

Psychedelics may mess up brain activity scans

futurity.org · Dec 15, 2025 · Washington U. in St. Louis

Psilocybin Article Clinical Research Safety

December 5, 2025

A dose of psilocybin, a dash of rabies point to treatment for depression

news.cornell.edu · Dec 5, 2025 · David Nutt, Cornell Chronicle

Psilocybin Clinical Consciousness Research

November 26, 2025

What the Cancer Community Actually Needs from Psychedelic Care

psychedelicstoday.com · Nov 26, 2025 · Anne Hamilton, JD, MA

Psilocybin Article Clinical Community Safety